BODE Index for COPD Survival
ورودیهای بالینی بیمار
حداقل ۱۰ — حداکثر ۱۵۰ • واحد: %
حداقل ۰ — حداکثر ۱۰۰۰ • واحد: meters
حداقل ۱۰ — حداکثر ۵۰ • واحد: kg/m²
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Quartile 1 (Low Risk)0–2
- Quartile 2 (Moderate Risk)3–4
- Quartile 3 (High Risk)5–6
- Quartile 4 (Very High Risk)7–10
The BODE Index for COPD Survival calculates predicting survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). Key inputs include fev1 percent predicted. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). The BODE Index (Body-Mass Index, Obstruction, Dyspnea, Exercise) is a multidimensional grading system that better predicts survival than FEV1 alone.
Clinical Indication
The BODE Index for COPD Survival is indicated for bedside clinical practice to support Predicts survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). The BODE Index (Body-Mass Index, Obstruction, Dyspnea, Exercise) is a multidimensional grading system that better predicts survival than FEV1 alone.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Does not guide specific treatment decisions but provides prognostic information.
BODE Index = FEV1 score + 6MWD score + mMRC score + BMI score. Total score ranges from 0-10 points with higher scores indicating worse prognosis.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| fev1_percent_predicted | float | Yes | FEV1 as percentage of predicted normal value based on age, sex, height, and ethnicity(%) |
| six_minute_walk_distance | integer | Yes | Distance walked in meters during standardized 6-minute walk test(meters) |
| mmrc_dyspnea_scale | string | Yes | Modified Medical Research Council Dyspnea Scale assessing functional disability due to breathlessness |
| body_mass_index | float | Yes | Body mass index in kg/m²(kg/m²) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2 | Quartile 1 (Low Risk) | BODE Index 0-2 points |
| 3–4 | Quartile 2 (Moderate Risk) | BODE Index 3-4 points |
| 5–6 | Quartile 3 (High Risk) | BODE Index 5-6 points |
| 7–10 | Quartile 4 (Very High Risk) | BODE Index 7-10 points |
Evidence-Based References (EBM)
- Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.DOI: 10.1056/NEJMoa021322
- Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005 Dec;128(6):3810-6. doi: 10.1378/chest.128.6.3810.DOI: 10.1378/chest.128.6.3810
- Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J. 2005 Oct;26(4):630-6. doi: 10.1183/09031936.05.00045505.DOI: 10.1183/09031936.05.00045505
- Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009 Aug 29;374(9691):704-11. doi: 10.1016/S0140-6736(09)61301-5.DOI: 10.1016/S0140-6736(09)61301-5